Institute for Cell, Gene, and Immunotherapy
![DNA in lab](/sites/clinicalaffairs.umn.edu/files/2021-04/iStock-680040394.jpg)
Speeding translation of innovation to clinical care
Accelerating the development and testing of novel cell, gene and immune-based therapeutics that hold promise in the treatment of life-threatening diseases.
Connecting Clinical Research to Industry and Community
The institute will build on existing strengths at the University, further develop high-tech core capabilities, and connect to industry partners with access to new technologies in order to speed translation of innovation to clinical care. Read about our Core Services.
![John Wagner](/sites/clinicalaffairs.umn.edu/files/2021-04/johnwagner125.jpg)
John Wagner, MD has been a key contributor to establishing the University’s international leadership in stem cell and umbilical cord blood transplantation. He is a professor of pediatrics, Co-Director of the Center for Translational Medicine, Program Co-Leader of Transplant Biology and Therapy within the Masonic Cancer Center and Director of the Pediatric Blood and Marrow Transplant Program from 2004 to July 2019.